These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11888657)
1. Anti-HIV activity of a glycoprotein from first trimester placental tissue. Kondapi AK; Hafiz MA; Sivaram T Antiviral Res; 2002 Apr; 54(1):47-57. PubMed ID: 11888657 [TBL] [Abstract][Full Text] [Related]
2. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry. Roda Rani KP; Pelluru D; Kondapi AK Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of niphatevirin, a human-immunodeficiency-virus-inhibitory glycoprotein from the marine sponge Niphates erecta. O'Keefe BR; Beutler JA; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Sowder RC; Henderson LE; Pannell LK; Pomponi SA; Boyd MR Eur J Biochem; 1997 Apr; 245(1):47-53. PubMed ID: 9128723 [TBL] [Abstract][Full Text] [Related]
4. Identification of the potential regions of Epap-1 that interacts with V3 loop of HIV-1 gp120. Bhaskar C; Reddy PS; Chandra KS; Sabde S; Mitra D; Kondapi AK Biochim Biophys Acta; 2013 Apr; 1834(4):780-90. PubMed ID: 23360764 [TBL] [Abstract][Full Text] [Related]
5. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646 [TBL] [Abstract][Full Text] [Related]
6. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592 [TBL] [Abstract][Full Text] [Related]
7. Role of curdlan sulfate in the binding of HIV-1 gp120 to CD4 molecules and the production of gp120-mediated TNF-alpha. Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Sekigawa I; Hashimoto H; Hirose S; Murakami T; Yamamoto N; Mimura T; Kaneko Y Microbiol Immunol; 1997; 41(9):741-5. PubMed ID: 9343827 [TBL] [Abstract][Full Text] [Related]
8. A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding. Wang HG; Williams RE; Lin PF Curr Pharm Des; 2004; 10(15):1785-93. PubMed ID: 15180540 [TBL] [Abstract][Full Text] [Related]
9. Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro. Seppälä M; Jiang S; Strick N; Lin K; Li YY; Koistinen H; Koistinen R; Neurath AR Lab Invest; 1997 Aug; 77(2):127-30. PubMed ID: 9274854 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions. Guo Q; Ho HT; Dicker I; Fan L; Zhou N; Friborg J; Wang T; McAuliffe BV; Wang HG; Rose RE; Fang H; Scarnati HT; Langley DR; Meanwell NA; Abraham R; Colonno RJ; Lin PF J Virol; 2003 Oct; 77(19):10528-36. PubMed ID: 12970437 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535 [TBL] [Abstract][Full Text] [Related]
12. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Moore JP; McKeating JA; Weiss RA; Sattentau QJ Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501 [TBL] [Abstract][Full Text] [Related]
13. Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor. Vermeire K; Schols D Expert Opin Investig Drugs; 2005 Oct; 14(10):1199-212. PubMed ID: 16185162 [TBL] [Abstract][Full Text] [Related]
14. Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation. Autiero M; Gaubin M; Mani JC; Castejon C; Martin M; el Marhomy S; Guardiola J; Piatier-Tonneau D Eur J Biochem; 1997 Apr; 245(1):208-13. PubMed ID: 9128743 [TBL] [Abstract][Full Text] [Related]
15. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386 [TBL] [Abstract][Full Text] [Related]
16. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus. Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053 [TBL] [Abstract][Full Text] [Related]
17. CD4-affinity purification of recombinant and native HIV gp120 and comparison of the affinity constants for the receptor. Moritz D; Dirckx L; Mous J; Schneider J FEBS Lett; 1990 Nov; 275(1-2):146-50. PubMed ID: 2261984 [TBL] [Abstract][Full Text] [Related]
18. Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. Collins RA; Ng TB Life Sci; 1997; 60(25):PL383-7. PubMed ID: 9194694 [TBL] [Abstract][Full Text] [Related]
19. RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses. Fujiwara M; Ashida N; Okamoto M; Mizuta T; Ide T; Hanasaki Y; Katsuura K; Sawada H; Shigeta S; Konno K; Yokota T; Baba M Antiviral Res; 1998 May; 38(2):141-9. PubMed ID: 9707376 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of adociavirin, a novel HIV-inhibitory protein from the sponge Adocia sp. O'Keefe BR; Erim T; Beutler JA; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Sowder RC; Johnson DG; Buckheit RW; Halliday S; Boyd MR FEBS Lett; 1998 Jul; 431(1):85-90. PubMed ID: 9684871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]